You are here

Publications

Found 778 results
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Buchman AR, Lue NF, Kornberg RD.  1988.  Connections between transcriptional activators, silencers, and telomeres as revealed by functional analysis of a yeast DNA-binding protein.. Mol Cell Biol. 8(12):5086-99.
Bosoy D, Peng Y, I Mian S, Lue NF.  2003.  Conserved N-terminal motifs of telomerase reverse transcriptase required for ribonucleoprotein assembly in vivo.. J Biol Chem. 278(6):3882-90.
Lue NF, Lin Y-C, I Mian S.  2003.  A conserved telomerase motif within the catalytic domain of telomerase reverse transcriptase is specifically required for repeat addition processivity.. Mol Cell Biol. 23(23):8440-9.
Gall JG, Crystal RG, Falck-Pedersen E.  1998.  Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.. J Virol. 72(12):10260-4.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Schnappinger D, O'Brien KM, Ehrt S.  2015.  Construction of conditional knockdown mutants in mycobacteria.. Methods Mol Biol. 1285:151-75.
Yu EYoung, Hsu M, Holloman WK, Lue NF.  2018.  Contributions of recombination and repair proteins to telomere maintenance in telomerase-positive and negative Ustilago maydis.. Mol Microbiol. 107(1):81-93.
Holloman WK, Dekker CA.  1971.  Control by cesium and intermediates of the citric acid cycle of extracellular ribonuclease and other enzymes involved in the assimilation of nitrogen.. Proc Natl Acad Sci U S A. 68(9):2241-5.
Ehrt S, Schnappinger D.  2006.  Controlling gene expression in mycobacteria.. Future Microbiol. 1(2):177-84.
Ehrt S, Guo XV, Hickey CM, Ryou M, Monteleone M, Riley LW, Schnappinger D.  2005.  Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.. Nucleic Acids Res. 33(2):e21.
Nathan C.  2015.  Cooperative development of antimicrobials: looking back to look ahead.. Nat Rev Microbiol. 13(10):651-7.
Rasoloson D, Shi L, Chong CR, Kafsack BF, Sullivan DJ.  2004.  Copper pathways in Plasmodium falciparum infected erythrocytes indicate an efflux role for the copper P-ATPase.. Biochem J. 381(Pt 3):803-11.
Moore JP, Klasse PJ.  2020.  COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds.. J Virol. 94(17)
Cheng Y-W, Pincas H, Bacolod MD, Schemmann G, Giardina SF, Huang J, Barral S, Idrees K, Khan SA, Zeng Z et al..  2008.  CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.. Clin Cancer Res. 14(19):6005-13.
Nicolás AL, Munz PL, Falck-Pedersen E, Young CS.  2000.  Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease.. Virology. 266(1):211-24.
Hu W, Zi Z, Jin Y, Li G, Shao K, Cai Q, Ma X, Wei F.  2019.  CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.. Cancer Immunol Immunother. 68(3):365-377.
Noguchi E, Homma Y, Kang X, Netea MG, Ma X.  2009.  A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1.. Nat Immunol. 10(5):471-9.
Orth P, Schnappinger D, Sum PE, Ellestad GA, Hillen W, Saenger W, Hinrichs W.  1999.  Crystal structure of the tet repressor in complex with a novel tetracycline, 9-(N,N-dimethylglycylamido)- 6-demethyl-6-deoxy-tetracycline.. J Mol Biol. 285(2):455-61.
Orth P, Alings C, Schnappinger D, Saenger W, Hinrichs W.  1998.  Crystallization and preliminary X-ray analysis of the Tet-repressor/operator complex.. Acta Crystallogr D Biol Crystallogr. 54(Pt 1):99-100.
Vandal OH, Gelb MH, Ehrt S, Nathan CF.  2006.  Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow-derived macrophages for the control of Mycobacterium tuberculosis in vitro.. Infect Immun. 74(3):1751-6.